Skip to Content

Patching Broken Hearts

Engineered tissue closely mimics the properties of the heart.
December 22, 2008

Heart patches grown from stem cells on biodegradable scaffolds could one day help treat heart attacks or congenital heart problems. But heart tissue is a mechanical marvel that’s hard to mimic. Any substitute must be flexible enough to permit the contractions that drive blood through the body but strong enough to withstand them.

Shaping up: A polymer scaffold (purple) encourages heart cells grown on it (green) to align themselves in the same direction.

A new scaffold material developed by researchers at MIT approximates the mechanical, structural, and electrical properties of natural heart tissue. It’s made of a biodegradable, rubber-band-like polymer carved with a laser into an accordionlike honeycomb pattern. The scaffold encourages cells grown on it to align themselves in the same direction, as they do in natural heart tissue. Because of the honeycomb pattern, the material is stiffer in the direction in which the cells are aligned than it is in the perpendicular direction, so it’s both strong and flexible. When stimulated with electricity, muscle grown on the honeycomb scaffold beats just like heart tissue. So far, by seeding their scaffolds with heart cells from newborn rats, the researchers have made thin tissues that very closely mimic the properties of the heart’s right ventricle.

In tissue engineering, it’s unusual to tailor scaffold material to a particular tissue type; most researchers just rely on generic scaffolds. The MIT researchers hope that their approach will help advance work on other engineered tissues, such as blood vessels, tendons, and ligaments, whose mechanical properties are also direction dependent. They’re building a library of honeycomb scaffolds with varying properties.

Keep Reading

Most Popular

10 Breakthrough Technologies 2024

Every year, we look for promising technologies poised to have a real impact on the world. Here are the advances that we think matter most right now.

Scientists are finding signals of long covid in blood. They could lead to new treatments.

Faults in a certain part of the immune system might be at the root of some long covid cases, new research suggests.

AI for everything: 10 Breakthrough Technologies 2024

Generative AI tools like ChatGPT reached mass adoption in record time, and reset the course of an entire industry.

What’s next for AI in 2024

Our writers look at the four hot trends to watch out for this year

Stay connected

Illustration by Rose Wong

Get the latest updates from
MIT Technology Review

Discover special offers, top stories, upcoming events, and more.

Thank you for submitting your email!

Explore more newsletters

It looks like something went wrong.

We’re having trouble saving your preferences. Try refreshing this page and updating them one more time. If you continue to get this message, reach out to us at customer-service@technologyreview.com with a list of newsletters you’d like to receive.